MAYNE PHARMA GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.235 AUD | -0.48% |
|
+4.30% | +18.21% |
| 02-26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
| 02-25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Generic Pharmaceuticals | -0.48% | +4.30% | +18.21% | +71.46% | -46.54% | 395M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- MYX Stock
- Charts Mayne Pharma Group Limited
- Comparison Chart